Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario

Authors: Cantini, L., Mentrasti, G., Russo, G.L., Signorelli, D., Pasello, G., Rijavec, E., Russano, M., Antonuzzo, L., Rocco, D., Giusti, R., Adamo, V., Genova, C., Tuzi, A., Morabito, A., Gori, S., Verde, N. La, Chiari, R., Cortellini, A., Cognigni, V., Pecci, F., Indini, A., De Toma, A., Zattarin, E., Oresti, S., Pizzutilo, E.G., Frega, S., Erbetta, E., Galletti, A., Citarella, F., Fancelli, S., Caliman, E., Della Gravara, L., Malapelle, U., Filetti, M., Piras, M., Toscano, G., Zullo, L., De Tursi, M., Di Marino, P., D’Emilio, V., Cona, M.S., Guida, A., Caglio, A., Salerno, F., Spinelli, G., Bennati, C., Morgillo, F., Russo, A., Dellepiane, C., Vallini, I., Sforza, V., Inno, A., Rastelli, F., Tassi, V., Nicolardi, L., Pensieri, V., Emili, R., Roca, E., Migliore, A., Galassi, T., Rocchi, M. L. Bruno, Berardi, R.

Source: In ESMO Open April 2022 7(2)

Benefits and Limitations of a Multidisciplinary Approach in Cancer Patient Management

Authors: Berardi R, Morgese F, Rinaldi S, Torniai M, Mentrasti G, Scortichini L, Giampieri R

Source: Cancer Management and Research, Vol Volume 12, Pp 9363-9374 (2020)

Subject Terms: multidisciplinary, tumor board, cancer patients, benefits, limitations, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.dovepress.com/benefits-and-limitations-of-a-multidisciplinary-approach-in-cancer-pat-peer-reviewed-article-CMAR; https://doaj.org/toc/1179-1322

Access URL: https://doaj.org/article/12182f5d3cd34344a212c3dbae6b72cb

Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH): Optimal Management

Authors: Mentrasti G, Scortichini L, Torniai M, Giampieri R, Morgese F, Rinaldi S, Berardi R

Source: Therapeutics and Clinical Risk Management, Vol Volume 16, Pp 663-672 (2020)

Subject Terms: siadh, hyponatremia, prognosis, neoplasms, lung cancer, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://www.dovepress.com/syndrome-of-inappropriate-antidiuretic-hormone-secretion-siadh-optimal-peer-reviewed-article-TCRM; https://doaj.org/toc/1178-203X

Access URL: https://doaj.org/article/cb35c0a170364cf4865e08b9642d6838

Carbon dating cancer: defining the chronology of metastatic progression in colorectal cancer

Authors: Lote, H., Spiteri, I., Ermini, L., Vatsiou, A., Roy, A., McDonald, A., Maka, N., Balsitis, M., Bose, N., Simbolo, M., Mafficini, A., Lampis, A., Hahne, J.C., Trevisani, F., Eltahir, Z., Mentrasti, G., Findlay, C., Kalkman, E.A.J., Punta, M., Werner, B., Lise, S., Aktipis, A., Maley, C., Greaves, M., Braconi, C., White, J., Fassan, M., Scarpa, A., Sottoriva, A. ^*, Valeri, N. ^*

Source: In Annals of Oncology June 2017 28(6):1243-1249

Elucidating the role of baseline and on-treatment nutritional status and body composition on clinical outcomes in advanced nsclc patients treated with immunotherapy

Authors: Mentrasti, G. ¹, Lunetti, S. ², Pecci, F. ¹, Mignini, V.E. ², Cola, C. ², Ferrara, M. ², Chiariotti, R. ¹, De Filippis, C. ¹, Temperoni, L. Angeli ², Copparoni, C. ¹, Cognigni, V. ¹, Bruschi, G. ³, Gualtieri, M. ¹, Lunerti, V. ¹, Santamaria, L. ¹, Agostinelli, V. ¹, Paoloni, F. ¹, Chiodi, N. ⁴, Cantini, L. ⁵, Burattini, L. ³, Taus, M. ², Berardi, R. ^{1, 4}

Source: In Clinical Nutrition ESPEN October 2024 63:1012-1013

EP.11A.15 NSCLC-ClustOpt: A Semi-Supervised Optimized Clustering to Stratify Patients with NSCLC on Immune Checkpoint Blockers Therapy

Authors: Paoloni, F., Pecci, F., Bruschi, G., Tola, E., Sbrollini, A., Galassi, T., Borgheresi, A., Cognigni, V., Cantini, L., Saini, K.S., Santamaria, L., Gualtieri, M., Lunerti, V., Di Pietro Paolo, M., Mazzanti, P., Agostinelli, V., Agostini, A., Mentrasti, G., Giovagnoni, A., Burattini, L., Berardi, R.

Source: In Journal of Thoracic Oncology October 2024 19(10) Supplement:S602-S602

Erratum to ‘Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario’: [ESMO Open Volume 7, Issue 2, April 2022, 100406]

Authors: Cantini, L., Mentrasti, G., Lo Russo, G., Signorelli, D., Pasello, G., Rijavec, E., Russano, M., Antonuzzo, L., Rocco, D., Giusti, R., Adamo, V., Genova, C., Tuzi, A., Morabito, A., Gori, S., La Verde, N., Chiari, R., Cortellini, A., Cognigni, V., Pecci, F., Indini, A., De Toma, A., Zattarin, E., Oresti, S., Pizzutilo, E.G., Frega, S., Erbetta, E., Galletti, A., Citarella, F., Fancelli, S., Caliman, E., Della Gravara, L., Malapelle, U., Filetti, M., Piras, M., Toscano, G., Zullo, L., De Tursi, M., Di Marino, P., D’Emilio, V., Cona, M.S., Guida, A., Caglio, A., Salerno, F., Spinelli, G.P., Bennati, C., Morgillo, F., Russo, A., Dellepiane, C., Vallini, I., Sforza, V., Inno, A., Rastelli, F., Tassi, V., Nicolardi, L., Pensieri, M.V., Emili, R., Roca, E., Migliore, A., Galassi, T., Rocchi, M.B.L., Berardi, R.

Source: In ESMO Open April 2022 7(2)

B23 - Bone pain control in Castration resistant prostate cancer (CRPC): retrospective analysis of first patients trated with Radium 223

Authors: Toma, I., Lancia, F., Scapoli, D., Frassoldati, A., Panareo, S., Santi, I., Cittanti, C., Bartolomei, M., Daniel, F., Moretti, A., Martella, L.R., Belluomini, L., Mentrasti, G.

Source: In Annals of Oncology October 2017 28 Supplement 6:vi24-vi24

A45 - The regorafenib issue: focus on efficacy and safety in pre-treated metastatic colorectal cancer from a real world experience

Authors: Daniel, F., Bannò, E., Belluomini, L., Martella, L.R., Lancia, F., Toma, I., Moretti, A., Mentrasti, G., Carandina, I., Marzola, M., Frassoldati, A.

Source: In Annals of Oncology October 2017 28 Supplement 6:vi15-vi16

EP17.06-01 COVID-19 Long-Lasting Effect on Lung Cancer Diagnoses in Italy: Update of the Real-World Multicenter COVID-DELAY Study

Authors: Mentrasti, G., Cognigni, V., Galassi, T., Signorelli, D., Pizzutilo, E.G., Martinelli, F., Lo Russo, G., Leporati, R., Ambrosini, P., Giusti, R., D'Amuri, S., Rocco, D., Della Gravara, L., Antonuzzo, L., Fancelli, S., Gori, S., Sernia, S., Ferrari, M., De Tursi, M., Di Marino, P., Di Maio, M., Salerno, F., Zumstein, L., Russano, M., Citarella, F., Adamo, V., Russo, A., Scimone, C., Sforza, V., Morabito, A., La Verde, N., Cona, M.S., Catalano, V., Emili, R., Sarti, D., Morgillo, F., Di Guida, G., Rocchi, M.B.L., Parisi, A., Berardi, R.

Source: In Journal of Thoracic Oncology November 2023 18(11) Supplement:S742-S743

648P Medium to long-term effects of the COVID-19 pandemic on colorectal cancer diagnosis and management in Italy: Preliminary findings from an updated analysis of the real-world multicenter COVID-DELAY study

Authors: Parisi, A., Gelsomino, F., Traisci, D., Barbin, F., Salvatore, L., di Pietro, F.R., Zoratto, F., Lanese, A., S. villani, Magnarini, A., Spallanzani, A., D'Ostilio, N., Bensi, M., Schietroma, F., Bisonni, R., Rocchi, M.B.L., Giampieri, R., Mentrasti, G., Berardi, R.

Source: In Annals of Oncology October 2023 34 Supplement 2:S455-S455

1065P Prospective assessment of nutritional status in patients with advanced non-small cell lung cancer and renal cell carcinoma treated with immune checkpoint inhibitors

Authors: Pecci, F., Mentrasti, G., Cognigni, V., Lunetti, S., Cola, C., Mignini, V.E., Santamaria, L., Agostinelli, V., Chiarotti, R., De Filippis, C., Gualtieri, M., Lunerti, V., Copparoni, C., Felicetti, C., Belletti, G., Tarantino, V., Parisi, A., Cantini, L., Taus, M., Berardi, R.

Source: In Annals of Oncology October 2023 34 Supplement 2:S643-S643

1621P miRNA signature as early predictor of hyponatremia and survival in lung cancer: Preliminary results from the ISA retrospective study

Authors: Mentrasti, G., Ambrosini, E., Giuliani, L., Chiodi, N., Liguori, C., Gualtieri, M., Bianchi, F., Barbisan, F., Goteri, G., Rocchi, M.B.L., Berardi, R.

Source: In Annals of Oncology September 2022 33 Supplement 7:S1282-S1283

OA01.02 Impact of COVID-19 Outbreak on Lung Cancer Diagnosis and Continuum of Care: Data From an Italian Multicenter Study

Authors: Cantini, L., Mentrasti, G., Siena, S., Pasello, G., Galetti, A., Caliman, E., Rocco, D., Adamo, V., Genova, C., Morabito, A., Gori, S., Rijavec, E., Chiari, R., Oldani, S., Caglio, A., De Tursi, M., Cortellini, A., Morgillo, F., Bennati, C., Guida, A., Spinelli, G.P., Emili, R., Roca, E., Indini, A., De Toma, A., Vallini, I., D'Emilio, V., Cognigni, V., Pecci, F., Migliore, A., Della Gravara, L., Frega, S., Zullo, L., Zattarin, E., Citarella, F., Russo, A., Fancelli, S., Oresti, S., Berardi, R.

Source: In Journal of Thoracic Oncology October 2021 16(10) Supplement:S848-S849

1616P Drop in early-stage colorectal cancer diagnoses after COVID-19: Preliminary report from the COVID-DELAY study

Authors: Mentrasti, G., Cognigni, V., Di Maio, M., Chiari, R., La Verde, N., Zichi, C., Aimar, G., De Vita, F., Marini, S., Cona, M.S., Pinterpe, G., Pecci, F., Migliore, A., Caravita, E., Rocchi, M.B.L., Bittoni, A., Giampieri, R., Cantini, L., Berardi, R.

Source: In Annals of Oncology September 2021 32 Supplement 5:S1151-S1151

1609P COVID-19 outbreak repercussions on breast cancer diagnoses and access to treatment: Preliminary data from the COVID-DELAY study

Authors: Berardi, R., Mentrasti, G., Crocetti, S., La Verde, N., Chiari, R., Cona, M.S., Nicolardi, L., De Filippis, C., Oldani, S., Pecci, F., Venanzi, F., Rocchi, M.B.L., Savini, A., Cantini, L., Pistelli, M.

Source: In Annals of Oncology September 2021 32 Supplement 5:S1149-S1149

35P Lung cancer diagnosis and continuum of care: How did the COVID-19 outbreak impact? Data from an Italian multicenter study

Authors: Cantini, L., Mentrasti, G., La Verde, N., Cona, M.S., Chiari, R., Martinelli, E., Morgillo, F., Nicolardi, L., Cortellini, A., Pensieri, V., Cognigni, V., Pinterpe, G., Galassi, T., Pecci, F., Mazzanti, P., Di Pietro Paolo, M., Giampieri, R., Berardi, R.

Source: In Journal of Thoracic Oncology April 2021 16(4) Supplement:S713-S713

FP12.06 GRIm-Score Variations Predict Outcome in Metastatic NSCLC Patients Treated with First-Line Pembrolizumab

Authors: Lenci, E., Cantini, L., Rinaldi, S., Pecci, F., Cognigni, V., Agostinelli, V., Mentrasti, G., Ranallo, N., Lupi, A., Paoloni, F., Cortellini, A., Ficorella, C., Chiari, R., Di Maio, M., Aerts, J., Dingemans, A., Nicolardi, L., Caglio, A., Aerts, S., Berardi, R.

Source: In Journal of Thoracic Oncology March 2021 16(3) Supplement:S219-S219

525P - KRAS mutations in circulating tumour DNA (ctDNA) in MRI-defined, high-risk, locally-advanced rectal cancer (LARC) patients (pts) from the EXPERT-C trial

Authors: Sclafani, F., Chau, I., Cunningham, D., Vlachogiannis, G., Eltahir, Z., Lampis, A., Braconi, C., Kalaitzaki, E., De Castro, D. Gonzalez, Wotherspoon, A., Capdevila, J., Glimelius, B., Cervantes, A., Begum, R., Lote, H., Mentrasti, G., Hahne, J.C., Tait, D., Brown, G., Valeri, N.

Source: In Annals of Oncology 1 October 2016 27 Supplement 6:vi173-vi173

This result is not displayed to guests.
Login for full access.